Do you want to read an article? Please log in or register.
Progression of regional grey matter atrophy in multiple sclerosis
Multiple Sclerosis
Related content
Multiple Sclerosis
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Brain.
Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL
doi: 10.1093/brain/awz212.
Multiple Sclerosis
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Brain.
Rocca MA, Sormani MP, Rovaris M, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Laroni A, Bergamaschi R, Martinelli V, Comi G, Filippi M
doi: 10.1093/brain/awx250.
Multiple Sclerosis
T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter
Sci Rep.
Kelemen P, Alaoui J, Sieron D, Chan A, Kamm CP, Heldner MR, Gralla J, Wiest R, Verma RK
doi: 10.1038/s41598-018-
RECOMMENDED
Multiple Sclerosis
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Neurology
Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira A, Sastre-Garriga J, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Lukas C, Bellenberg B, Barkhof F, Vrenken H, Preziosa P, Filippi M, MAGNIMS Study Group.
doi: 10.1212/WNL.0000000000011494
Multiple Sclerosis
Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy
Ann Neurol.
Sotirchos ES, Caldito NG, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, Nguyen J, Button J, Ogbuokiri E, Crainiceanu CM, Prince JL, Calabresi PA, Saidha S, International Multiple Sclerosis Visual System (IMSVISUAL) Consortium.
doi: 10.1002/ana.25738.
Multiple Sclerosis
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis
Mult Scler.
Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, Prince JL, Calabresi PA, Saidha S
doi: 10.1177/
Multiple Sclerosis
Deep gray matter volume loss drives disability worsening in multiple sclerosis
Ann Neurol.
Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group
doi: 10.1002/ana.25145.
Multiple Sclerosis
Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis
Neurology.
Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T
doi: 10.1212/WNL.
Multiple Sclerosis
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Brain.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP
doi: 10.1093/brain/aww258.